Imaging essential tremor

Movement Disorders

Volumn 25, Issue 6, 2010, Pages 679-686

  Isaias, Ioannis U ^a,b   Marotta, Giorgio ^c   Hirano, Shigeki ^d   Canesi, Margherita ^b   Benti, Riccardo ^c   Righini, Andrea ^e   Tang, Chengke ^d   Cilia, Roberto ^b   Pezzoli, Gianni ^b   Eidelberg, David ^d,f   Antonini, Angelo ^b,g,h  

^a UNIVERSITY OF MILAN   (Italy)

^b PARKINSON INSTITUTE   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e V BUZZI CHILDREN S HOSPITAL   (Italy)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g IRCCS SAN CAMILLO HOSPITAL   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

Author keywords

Essential tremor; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; DOPAMINE TRANSPORTER; ETHYL CYSTEINATE DIMER BICISATE TC 99M; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)TROPANE; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; AKINESIA; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISCRIMINANT ANALYSIS; DOPAMINERGIC SYSTEM; ESSENTIAL TREMOR; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROTEIN BINDING; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; BRAIN; DISCRIMINANT ANALYSIS; ESSENTIAL TREMOR; FEMALE; HUMANS; IODINE ISOTOPES; MALE; MIDDLE AGED; NEURAL PATHWAYS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 77951770621     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22870     Document Type: Article

References (44)

1. Deuschl G, Bain P, Brin M. Consensus statement of the movement disorder society on tremor: Ad Hoc Scientific Committee. Mov Disord 1998;13:2-23.
2. Deuschl G, Elble RJ. The pathophysiology of essential tremor. Neurology 2000;54:14-20.
3. Deuschl G, Raethjen J, Lindemann M, Krack P. The pathophysiology of tremor. Muscle Nerve 2001;24:716-735.
4. Pinto AD, Lang AE, Chen R. The cerebello thalamo cortical pathway in essential tremor. Neurology 2003;60:1985-1987. (Pubitemid 36736019)
5. Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry 2006;77:1235-1237. (Pubitemid 44654752)
6. Montgomery EB, Jr, Baker KB, Lyons K, Koller WC. Motor initiation and execution in essential tremor and Parkinson's disease. Mov Disord 2000;15:511-515. (Pubitemid 30333224)
7. Ozekmekci S, Kiziltan G, Vural M, Ertan S, Apaydin H, Erginoz E. Assessment of movement time in patients with essential tremor. J Neurol 2005;252:964-967. (Pubitemid 41186969)
8. Duval C, Sadikot AF, Panisset M. Bradykinesia in patients with essential tremor. Brain Res 2006;1115:213-216.
9. Jankovic J. Essential tremor: a heterogenous disorder. Mov Disord 2002;17:638-644.
10. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC. Olfactory function in essential tremor. Neurology 1992;42:1631-1632.
11. Liberini P, Parola S, Spano PF, Antonini L. Olfaction in Parkinson's disease: methods of assessment and clinical relevance. J Neurol 2000;247:88-96. (Pubitemid 30162521)
12. Louis ED, Bromley SM, Jurewicz EC, Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 2002;59:1631-1633. (Pubitemid 35387075)
13. Benito-León J, Louis ED, Bermejo-Pareja F,on behalf of the Neurological Disorders in Central Spain (NEDICES) Study Group. Risk of incidence Parkinson's disease and Parkinsonism in essential tremor: a population-based study. J Neurol Neurosurg Psychiatry 2009;80:423-425.
14. Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC, Watner D. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002;333:17-20. (Pubitemid 35223592)
15. Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007;130:3297-3307.
16. Shin DH, Han BS, Kim HS, Lee PH. Diffusion tensor imaging in patients with essential tremor. AJNR Am J Neuroradiol 2008;29:151-153.
17. Isaias IU, Canesi M, Benti R, et al. Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun 2008;29:349-353. (Pubitemid 351644383)
18. Schneider SA, Edwards MJ, Mir P, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22:2210-2215.
19. Eckert T, Feigin A, Lewis DE, Dhawan V, Frucht S, Eidelberg D. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 2007;22:167-173 (Pubitemid 46374756)
20. Hughes A, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
21. Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D. The metabolic anatomy of tremor in Parkinson's disease. Neurology 1998;51:803-810. (Pubitemid 28449263)
22. Isaias IU, Benti R, Cilia R, et al. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset. Neuroreport 2007;18:1499-1502. (Pubitemid 47295953)
23. Fahn SE, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders, Second ed. Baltimore, MD: Williams and Wilkins; 1988. p225-223.
24. Ma Y, Dhawan V, Mentis M, Chaly T, Spetsieris PG, Eidelberg D. Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study. Synapse 2002;45:125-133.
25. Kas A, Payoux P, Habert MO, et al. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images. J Nucl Med 2007;48:1459-1467. (Pubitemid 47397396)
26. Tzourio-Mazoyer N, De Schonen S, Crivello F, Reutter B, Aujard Y, Mazoyer B. Automated anatomical labelling of activations in spm using a macroscopic anatomical parcellation of the MNI MRI single subject brain. Neuroimage 2002;15:273-289. (Pubitemid 34852226)
27. Cilia R, Marotta G, Landi A, et al. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study. Clin Neurol Neurosurg 2009;111:140-146.
28. Asanuma K, Ma Y, Huang C, et al. The metabolic pathology of dopa-responsive dystonia. Ann Neurol 2005;57:596-600.
29. Jankovic J, Contant C, Perlmutter J. Essential tremor and Parkinson's disease. Neurology 1993;43:1447-1448.
30. Lee MS, Kim YD, Im JH, et al. 125I-IPT brain SPECT study in essential tremor and Parkinson's disease. Neurology 1999;52:1422-1426.
31. Lalley FM, Rossi GV, Baker WW. Tremor induction by intracaudate injections of bretylium, tetrabenazine, or mescaline: functional deficits in the caudate dopamine. J Pharm Sci 1973;62:1302-1307.
32. Kim JS. Delayed onset hand tremor caused by cerebral infarction. Stroke 1992;23:292-294.
33. Jellinger KA. Post mortem studies in Parkinson's disease - is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999;56:1-29.
34. Berezovskii VK, Oleshko NN. Electrophysiological characteristics of caudate-thalamic connections. Neurophysiology 1977;9:431-435.
35. Kopell BH, Rezai AR, Chang JW, Vitek JL. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease. Mov Disord 2006;21:238-246.
36. Caretti V, Stoffers D, Winogrodzka A, et al. Loss of thalamic serotonin transporters in early drug-naÿve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study. J Neural Transm 2008;115:721-729.
37. Sedgwick EM, Williams TD. Responses of single units in the inferior olive to stimulation of the limb nerves, peripheral skin receptors, cerebellum, caudate nucleus and motor cortex. J Physiol 1967;189:261-279.
38. Fox M, Williams TD. Responses evoked in the cerebellar cortex by stimulation of the caudate nucleus in the cat. J Physiol 1968;198:435-449.
39. Lorenz D, Deuschl G. Update on pathogenesis and treatment of essential tremor. Curr Opin Neurol 2007;20:447-452. (Pubitemid 47051993)
40. Staffen W, Mair A, Unterrainer J, Trinka E, Ladurner G. Measuring the progression of idiopathic Parkinson's disease with [123I]-CIT SPECT. J Neural Transm 2000;107:543-552. (Pubitemid 30251738)
41. Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs. levodopa on Parkinson disease progression. JAMA 2002;287:1653-1661. (Pubitemid 34289217)
42. Pirker W, Djamshidian S, Asenbaum S, et al. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov Disord 2002;17:45-53.
43. Marek K, Innis R, van Dyck C, et al. [123I]B-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 2001;57:2089-2094.
44. Chouker M, Tatsch K, Linke R, Pogarell O, Hahn K, Schwarz J. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years. Nucl Med Commun 2001;22:721-725